Delivering AI-Powered

Real-World DataPersonalized MedicineObservational ResearchChart Abstraction

Solutions

Learn More

How We Help

Real-World Data and Insights

Digital Phenotyping and Personalized Medicine

Tech-Enabled Prospective and Retrospective Evidence Generation

Trusted by global companies

Frost & Sullivan: Life Sciences RWE Report

"2025: A top contender in growth and innovation"

OM1 is named a top contender in growth and innovation in the 2025 Frost Radar Life Sciences Real World Evidence Solutions Report.

ISPOR Poster (2025)

Poster: “Suicidal Ideation in Patients Treated with Glucagon-like Peptide 1 Receptor (GLP1) Agonists: A Retrospective Real-World Analysis”

ISPOR Top 5% Poster

Poster: “Predictors of Low Disease Activity/ Remission Amongst Rheumatoid Arthritis Patients Experiencing Inadequate Response to Biologic/ Targeted Synthetic Disease-Modifying Antirheumatic Drugs

Frost & Sullivan Award

"New Product Innovation"

OM1 is the recipient of the 2024 Frost & Sullivan Award in “New Product Innovation in North America RWE Analytics”

Poster Finalist

A Top 5% Finalist for ISPOR 2024 Research Presentation Awards in "AI & HEOR"

Poster: “Addressing Gaps in Real-World Data Sources through Automated Extraction of Psychiatric Comorbidities and Medication Side Effects from Clinical Notes”

News

21 May 2025

Understanding the link between GLP-1 therapies and suicidal ideation using real-world data

13 May 2025

OM1’s PhenOM® Foundation AI Surpasses One Billion Years of Health History in Model Training

08 May 2025

OM1 to Present Groundbreaking Research on GLP-1 Agonists and Suicidal Ideation at ISPOR 2025

› See All News

Webinar

Hard to Define, Harder to Find: The Latest in AI Applied to Real-World Data to Understand & Predict Treatment Resistant Depression

Accelerate R&D with a better, more precise way to identify patients, broaden access to advanced therapies, and improve outcomes.

E-Book

Click to read PhenOM

This ebook explores powerful insights and analyses that leverage AI models and digital phenotyping, built on patient data from a network of over 300 million lives, to generate personalized insights around treatments, diagnosis, utilization, risks, and trials.

June 16 – June 20 • Washington, D.C.

Join OM1 at DIA Annual in D.C. to explore real-world data and AI for research and personalized medicine.